An App-based Instructional Platform to Improve Eye Drop Recall

Description

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule. At one month, both groups will be assessed on their eye drop regimen recall.

Conditions

Glaucoma

Study Overview

Study Details

Study overview

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule. At one month, both groups will be assessed on their eye drop regimen recall.

Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens

An App-based Instructional Platform to Improve Eye Drop Recall

Condition
Glaucoma
Intervention / Treatment

-

Contacts and Locations

San Francisco

San Francisco General Hospital, San Francisco, California, United States, 94110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * patients with a diagnosis of glaucoma (any type)
  • * drop regimen of at least 2 pressure-lowering drops
  • * languages supported at this time: English, Spanish, Cantonese
  • * concurrent eye conditions necessitating additional eye drops
  • * inability to self-administer eye drops
  • * inability to engage with app (either visual or other barrier)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Frank Brodie, MD, PRINCIPAL_INVESTIGATOR, UCSF, Department of Ophthalmology

Study Record Dates

2025-12-01